Fumio Sugawara Selected Research

Fumio Sugawara Research Topics

Disease

46	Neoplasms (Cancer) 01/2022 - 01/2002
6	Infections 01/2019 - 11/2013
4	Carcinoma (Carcinomatosis) 03/2019 - 11/2009
4	Inflammation (Inflammations) 08/2010 - 05/2005
3	Neuroblastoma 05/2008 - 05/2004
3	Stomach Neoplasms (Stomach Cancer) 07/2002 - 02/2002
2	Hypoxia (Hypoxemia) 01/2022 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2016 - 07/2004
2	Parkinson Disease (Parkinson's Disease) 01/2011 - 05/2008
1	Malignant Mesothelioma 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Human Influenza (Influenza) 07/2019
1	Nervous System Diseases (Neurological Disorders) 04/2016
1	Wounds and Injuries (Trauma) 04/2016
1	Stroke (Strokes) 04/2016
1	Hepatitis B 12/2015
1	Reinfection 12/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Edema (Dropsy) 08/2014
1	Anaphylaxis (Anaphylactic Shock) 08/2014
1	Hepatitis A (Hepatitis, Infectious) 12/2013
1	Autoimmune Diseases (Autoimmune Disease) 01/2013
1	Rheumatoid Arthritis 01/2013

Drug/Important Bio-Agent (IBA)

11	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 05/2005
11	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 08/2013 - 01/2003
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2005
5	Pharmaceutical PreparationsIBA 12/2015 - 07/2005
5	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2013 - 01/2010
4	trioctyl phosphine oxide (TOPO)IBA 08/2013 - 05/2005
4	EnzymesIBA 08/2013 - 05/2005
4	Small Interfering RNA (siRNA)IBA 08/2012 - 02/2008
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 02/2002
3	Deoxyribonuclease I (Nickase)IBA 08/2013 - 05/2005
3	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2011 - 10/2003
3	GemininIBA 06/2008 - 02/2008
3	epolactaeneIBA 05/2008 - 05/2004
3	dehydroaltenusinIBA 01/2007 - 02/2002
2	Radiation-Sensitizing AgentsIBA 01/2022 - 01/2021
2	Biological ProductsIBA 07/2019 - 12/2011
2	MA026IBA 05/2017 - 12/2013
2	Tamoxifen FDA LinkGeneric 09/2015 - 01/2013
2	RoxithromycinIBA 01/2015 - 01/2013
2	Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA 08/2013 - 11/2009
2	bacteriophage T7 RNA polymerase (T7 RNA polymerase)IBA 08/2013 - 11/2009
2	IMP DehydrogenaseIBA 08/2013 - 11/2009
2	Cisplatin (Platino)FDA LinkGeneric 11/2012 - 07/2005
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2012 - 11/2009
2	1- mono- O- acyl- 3- O- (alpha- D- sulfoquinovosyl)- glycerideIBA 08/2012 - 05/2008
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2011 - 11/2005
2	CamptothecinIBA 12/2011 - 11/2005
2	Etoposide (VP 16)FDA LinkGeneric 05/2011 - 07/2005
2	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 01/2011 - 05/2008
2	neoechinulin AIBA 01/2011 - 07/2004
2	NeurotoxinsIBA 01/2011 - 05/2008
2	DiglyceridesIBA 09/2009 - 10/2003
2	DNA Polymerase I (Klenow Fragment)IBA 01/2007 - 05/2005
2	GlycolipidsIBA 01/2007 - 07/2002
2	sulfoquinovosylacylglycerolIBA 01/2006 - 11/2005
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2003 - 02/2003
2	sulfolipidsIBA 10/2003 - 01/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2002 - 01/2002
1	Messenger RNA (mRNA)IBA 01/2022
1	AsbestosIBA 01/2022
1	Thromboplastin (Tissue Factor)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	pyrenocine AIBA 12/2019
1	NucleosidesIBA 07/2019
1	sulfoquinovosylacylpropanediolIBA 03/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	Chloramphenicol (Chloromycetin)FDA Link 01/2019
1	LipidsIBA 12/2018
1	Gadolinium DTPA (Magnevist)FDA Link 12/2018
1	Oxyhemoglobins (Oxyhemoglobin)IBA 12/2018
1	Oxygen (Dioxygen)IBA 12/2018
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 12/2018
1	Claudin-1IBA 05/2017
1	Glutamic Acid (Glutamate)FDA Link 04/2016
1	vanitaracin AIBA 12/2015
1	sodium-bile acid cotransporterIBA 12/2015
1	PolyketidesIBA 12/2015
1	Antiviral Agents (Antivirals)IBA 12/2015
1	ridaifen GIBA 09/2015
1	MacrolidesIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2015
1	karuquinone BIBA 09/2014
1	karuquinone AIBA 09/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2014
1	Anti-Allergic Agents (Antiallergic Agents)IBA 08/2014
1	4-hydroxyphenylethanolIBA 08/2014
1	Immunoglobulin E (IgE)IBA 08/2014
1	sulochrinIBA 11/2013
1	catechol (pyrocatechol)IBA 08/2013
1	Methotrexate (Mexate)FDA LinkGeneric 01/2013

Therapy/Procedure

4	Radiotherapy 01/2022 - 12/2018
2	Intravenous Injections 03/2019 - 12/2018
2	Drug Therapy (Chemotherapy) 01/2013 - 10/2003
2	Transplantation 10/2003 - 02/2003
1	Radioimmunotherapy 01/2022
1	Intravenous Administration 03/2019